Malaria prophylaxis for Canadian travellers.
D000655:Amodiaquine / Q000008:administration & dosage; D002170:Canada; D002738:Chloroquine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D003622:Dapsone / Q000494:pharmacology; D004318:Doxycycline / Q000008:administration & dosage; D004338:Drug Combinations / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008288:Malaria / Q000517:prevention & control*; D010961:Plasmodium / Q000187:drug effects; D010963:Plasmodium falciparum / Q000187:drug effects; D011247:Pregnancy; D011292:Premedication; D002727:Proguanil / Q000494:pharmacology; D011739:Pyrimethamine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D011803:Quinine / Q000494:pharmacology; D013413:Sulfadoxine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D014195:Travel
D004338:Drug Combinations; D000655:Amodiaquine; C001205:fanasil, pyrimethamine drug combination; C001678:Maloprim; D013413:Sulfadoxine; D002738:Chloroquine; D003622:Dapsone; D011803:Quinine; D004318:Doxycycline; D002727:Proguanil; D011739:Pyrimethamine